Elite in Pol 3-Related Leukodystrophy

Genevieve Bernard

Montreal, QC, CA 
Elite in Pol 3-Related Leukodystrophy
Montreal, QC, CA 
OverviewLocationsClinical Research

Overview

Genevieve Bernard practices in Montreal, Canada. Ms. Bernard is rated as an Elite expert by MediFind in the treatment of Pol 3-Related Leukodystrophy. Her top areas of expertise are Pol 3-Related Leukodystrophy, Leukodystrophy, CACH Syndrome, Gastrostomy, and Reconstructive Urology Surgery.

Her clinical research consists of co-authoring 154 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 20 articles in the study of Pol 3-Related Leukodystrophy.

Gender
Female

Locations

Montreal, QC, Canada
Other Locations
Montreal, Canada
Quebec, QC G1J1Z4, Canada
Ottawa, ON, Canada
Laval, QC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Global, Multicenter, Single-arm, Matched External Control Study of Intrathecal SHP611 in Subjects With Late Infantile Metachromatic Leukodystrophy
A Global, Multicenter, Single-arm, Matched External Control Study of Intrathecal SHP611 in Subjects With Late Infantile Metachromatic Leukodystrophy
Enrollment Status: Active_not_recruiting
Publish Date: March 07, 2025
Intervention Type: Drug
Study Drug: SHP611
Study Phase: Phase 2
A Phase 1/2 Open-Label, Multicenter Dose-Ranging and Confirmatory Study to Assess the Safety, Tolerability and Efficacy of PBKR03 Administered to Pediatric Subjects With Early Infantile Krabbe Disease (Globoid Cell Leukodystrophy)
A Phase 1/2 Open-Label, Multicenter Dose-Ranging and Confirmatory Study to Assess the Safety, Tolerability and Efficacy of PBKR03 Administered to Pediatric Subjects With Early Infantile Krabbe Disease (Globoid Cell Leukodystrophy)
Enrollment Status: Suspended
Publish Date: January 18, 2024
Intervention Type: Biological
Study Drug: PBKR03
Study Phase: Phase 1/Phase 2
A Prospective and Retrospective Data Collection Study to Evaluate Outcomes in Males ≤17 Years of Age Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Cerebral Adrenoleukodystrophy
A Prospective and Retrospective Data Collection Study to Evaluate Outcomes in Males ≤17 Years of Age Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Cerebral Adrenoleukodystrophy
Enrollment Status: Terminated
Publish Date: May 21, 2020
Intervention Type: Genetic
View 2 Less Clinical Trials

152 Total Publications

Comprehensive genotype-phenotype analysis in POLR3-related disorders.
Comprehensive genotype-phenotype analysis in POLR3-related disorders.
Journal: HGG advances
Published: April 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Bernard's expertise for a condition
ConditionClose
View All 16 Advanced Conditions
View All 55 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile